Search

Author/Creator Short, N.

1. P355: MINI-HYPER-CVD PLUS INOTUZUMAB OZOGAMICIN, WITH OR WITHOUT BLINATUMOMAB, IN OLDER ADULTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: UPDATES FROM A PHASE II TRIAL. (23rd June 2022)

Authors:
Haddad, F.; Kantarjian, H.; Short, N.; Ravandi, F.; Jain, N.; Macaron, W.; Kadia, T.; Alvarado, Y.; Daver, N.; Borthakur, G.; DiNardo, C.; Konopleva, M.; Wierda, W.; Jacob, J.; Roy, E.; Loiselle, C.; Milton, A.; Rivera, J.; Garris, R.; Jabbour, E.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
255
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P703: ASSOCIATION BETWEEN BARIATRIC SURGERY AND OUTCOMES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH ORAL TYROSINE KINASE INHIBITORS. (23rd June 2022)

Authors:
Haddad, F.; Kantarjian, H.; Jabbour, E.; Short, N.; Bidikian, A.; Ning, J.; Xiao, L.; Pemmaraju, N.; Marx, K.; Ravandi, F.; Sasaki, K.; Issa, G.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
598
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P368: A PHASE II STUDY OF INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF MEASURABLE RESIDUAL DISEASE-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA. (23rd June 2022)

Authors:
Senapati, J.; Kantarjian, H.; Short, N.; Alvarado, Y.; Burger, J.; Jain, N.; Konopleva, M.; Ravandi, F.; DiNardo, C.; Masarova, L.; Sasaki, K.; Thompson, P. A.; Ferrajoli, A.; Jacob, J. O.; Mayor, E. D.; Milton, A. M.; Loiselle, C.; Garris, R. S.; Jabbour, E. J.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
268
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P760: PATTERNS OF HYPOMETHYLATING AGENT FAILURE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES. (23rd June 2022)

Authors:
Chien, K.; Kim, K.; Li, Z.; Kanagal Shamanna, R.; Ong, F.; Montalban Bravo, G.; Kadia, T.; Jabbour, E.; Pemmaraju, N.; Hammond, D.; Short, N.; Ravandi, F.; Alvarado, Y.; Pierce, S.; Dong, X. Q.; Kantarjian, H.; Garcia-Manero, G.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
655
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P1194: A PHASE IB TRIAL OF ITACITINIB COMBINED WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL). (23rd June 2022)

Authors:
Kadia, T.; Ravandi, F.; Borthakur, G.; Jabbour, E.; Montalban-Bravo, G.; Adewale, L.; Pierce, S.; Lacke, C.; Brandt, M.; Short, N.; Jain, N.; Burger, J.; Ferrajoli, A.; Wierda, W.; Kantarjian, H.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1080
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P541: OUTCOMES AND MANAGEMENT OF PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PRESENTING WITH HYPERLEUKOCYTOSIS. (23rd June 2022)

Authors:
Haddad, F.; Sasaki, K.; Abuasab, T.; Venugopal, S.; Rivera Delgado, D.; Bazinet, A.; Babakhanlou, R.; Kim, K.; Senapati, J.; Ong, F.; Desikan, S.; Short, N.; Pemmaraju, N.; Borthakur, G.; DiNardo, C.; Daver, N.; Jabbour, E.; Garcia-Manero, G.; Ravandi, F.; Kadia, T.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
440
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P770: A COMPARATIVE STUDY OF LEUKEMIC TRANSFORMATION IN THERAPY-RELATED AND DE NOVO MYELODYSPLASTIC SYNDROME AFTER HYPOMETHYLATING AGENT FAILURE. (23rd June 2022)

Authors:
Kim, K.; Ong, F.; Li, Z.; Kanagal-Shamanna, R.; Montalban-Bravo, G.; Kadia, T.; Jabbour, E.; Pemmaraju, N.; Hammond, D.; Short, N.; Ravandi, F.; Alvarado, Y.; Pierce, S.; Dong, X. Q.; Kantarjian, H.; Garcia-Manero, G.; Chien, K.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
665
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. P757: RESULTS OF A PHASE 1 STUDY OF AZACITIDINE COMBINED WITH VENETOCLAX FOR TREATMENT-NAIVE AND RELAPSED HIGH-RISK MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA. (23rd June 2022)

Authors:
Bazinet, A.; Jabbour, E.; Kantarjian, H.; Chien, K.; DiNardo, C.; Ohanian, M.; Daver, N.; Kanagal-Shamanna, R.; Kadia, T.; Takahashi, K.; Masarova, L.; Short, N.; Alvarado, Y.; Thompson, P.; Montalban-Bravo, G.; Yilmaz, M.; Ravandi, F.; Konopleva, M.; Andreeff, M.; Kornblau, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
652
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. P784: A PHASE I/II STUDY OF VENETOCLAX IN COMBINATION WITH ASTX727 (DECITABINE/CEDAZURIDINE) IN TREATMENT‐NAÏVE HIGH‐RISK MYELODYSPLASTIC SYNDROME (MDS) OR CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML). (23rd June 2022)

Authors:
Venugopal, S.; kantarjian, H.; Maiti, A.; Short, N.; Montalban-Bravo, G.; Alvarado, Y.; Chien, K. S.; Kanagal-Shamanna, R.; Pemmaraju, N.; Daver, N.; Kadia, T.; Borthakur, G.; Jabbour, E.; Garcia-Manero, G.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
679
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. P371: HYPER-CVAD WITH SEQUENTIAL BLINATUMOMAB, WITH OR WITHOUT INOTUZUMAB OZOGAMICIN, IN ADULTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA. (23rd June 2022)

Authors:
Short, N.; Kantarjian, H.; Ravandi, F.; Yilmaz, M.; Kadia, T.; Thompson, P.; Huang, X.; Konopleva, M.; Ferrajoli, A.; Jain, N.; Sasaki, K.; Alvarado, Y.; Borthakur, G.; Dinardo, C.; Ohanian, M.; Macaron, W.; Kornblau, S.; Zhao, M.; Kwari, M.; Loiselle, C.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
271
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search